Tetraphase Pharmaceuticals' IPO

Tetraphase Pharmaceuticals raised a round of funding on March 20, 2013. Investors include Public.

Tetraphase Pharmaceuticals discovers and develops new tetracycline antibiotics to treat drug resistant bacterial infections using technology developed by Dr. Andrew Myers Professor of Chemistry and Ch…

Articles about Tetraphase Pharmaceuticals' IPO: